Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 15 Papillomavirus Infections 9 Uterine Cervical Neoplasms 7 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 5 Prostatic Neoplasms 4 Neuroendocrine Tumors 4 Neoplasm Metastasis 4 Myasthenia Gravis 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Lung Neoplasms 3 Autoimmune Diseases 3 Thyroid Diseases 2 Pancreatic Cyst 2 Neuroblastoma 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 COVID-19 2 Brain Neoplasms 2 Abortion, Spontaneous 2

Interventions

Cancer Vaccines 2 Adjuvants, Immunologic 2 veliparib 1 sargramostim 1 glutathione pegylated liposomal doxorubicin 1 etoposide phosphate 1 Vincristine 1 Trastuzumab 1 Tissue Banks 1 Sunitinib 1 Modafinil 1 Methotrexate 1 Leucovorin 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Data Collection 1 Cytarabine 1 Cyclophosphamide 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Nervous System Neoplasms × Data Collection × Clear all

NCT04516720 2025-02-12

BDD-NO

Institut du Cancer de Montpellier - Val d'Aurelle

Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡